NRX Pharmaceuticals Inc. buy BiotechBee
Start price
10.01.23
/
50%
€1.13
Target price
31.07.24
€2.00
Performance (%)
-49.56%
End price
05.05.23
€0.57
Summary
This prediction ended on 05.05.23 with a price of €0.57. The BUY prediction by BiotechBee for NRX Pharmaceuticals Inc. performed very badly with a performance of -49.56%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| NRX Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | -2.195% | 0.670% | 0.546% | 51.111% |
| iShares Nasdaq 100 | -2.629% | 2.992% | 34.108% | 91.988% |
| iShares Nikkei 225® | -2.021% | 3.141% | 53.424% | 65.852% |
| iShares S&P 500 | -1.670% | 2.405% | 23.220% | 66.636% |
According to BiotechBee what are the pros and cons of NRX Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread NRX Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 2,0
In the thread Trading NRX Pharmaceuticals Inc.
Buy beendet

